Finding   Capital Investments 

In today's challenging fundraising climate, identifying the right investors and securing  venture capital is more crucial than ever for biotech startups to remain competitive in the life sciences industry. Our panel of expert will provide valuable insights into the current market for dilutive capital investment types, emerging therapeutic areas, and what investors seek in startup companies. 

We invite you to join us on May 31st, 3pm-5pm at The Wistar Institute (3601 Spruce St.) to gain an understanding of the current state of dilutive capital investments and meet new and established faces in our region's venture capital scene.

Moderator:

Michele Washko

President & CEO

Life Sciences Greenhouse Investments

Panelists:

Lorenzo Pellegrini, PhD

Managing Partner

Hatch Biofund

Frederick Jones, MD

Partner

BioAdvance

Kathie Jordan, PhD

Managing Director

Healthcare Investment Group

Ben Franklin Technology Partners of Southeastern Pennsylvania